Compare Heron Therapeutics Inc (HRTX) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Utilities Select Sector SPDR Fund — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Utilities Select Sector SPDR Fund trades at $41.23 (market cap $23.28B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 314.4× Heron Therapeutics Inc's market cap, and Utilities Select Sector SPDR Fund is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| HRTX | XLU | |
|---|---|---|
Market Cap | $74.04M | $23.28B |
Volume | 3,668,095 | 44,925,171 |
Sector | Health | — |
52-Week High | $1.49 | $47.73 |
52-Week Low | $0.27 | $39.25 |
Typical Hold Time | 35 Days | 80 Days |
Enterprise Value | $180.78M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
XLU, the Utilities Select Sector SPDR ETF, trades at $41.15, down 0.02% on the day, and is near recent lows amid sector-wide pressure from rising interest rates. Technical indicators show a mixed but overall bullish signal, with moving averages bullish and oscillators neutral. The ETF recently hit a 52-week low, reflecting investor concerns over utility stocks as defensive plays in a higher-rate environment. News highlights oversold conditions and debates over AI-driven power demand versus regulatory hurdles.
Outlook remains cautious; while oversold conditions may attract contrarian buyers, persistent rate hikes and regulatory freezes on data centers pose headwinds. The dividend yield offers income, but sector volatility requires careful risk management amid macroeconomic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
